| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion binding | PITPNM2 TRPM4 DCHS2 LPCAT1 STAB2 DSC1 MYO5A MATN1 PCDHGA1 PCDH11Y CDH23 MATN4 GCH1 CUBN GLCE ITSN2 RHBDL3 C1R ASTN2 PLCB4 PLSCR2 ATP2B2 | 1.25e-06 | 749 | 181 | 22 | GO:0005509 |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | 2.71e-05 | 65 | 181 | 6 | GO:0004714 | |
| GeneOntologyMolecularFunction | histone H3 demethylase activity | 1.13e-04 | 28 | 181 | 4 | GO:0141052 | |
| GeneOntologyMolecularFunction | histone H3K36 demethylase activity | 1.15e-04 | 11 | 181 | 3 | GO:0051864 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 1.23e-04 | 85 | 181 | 6 | GO:0019199 | |
| GeneOntologyMolecularFunction | histone demethylase activity | 1.70e-04 | 31 | 181 | 4 | GO:0032452 | |
| GeneOntologyMolecularFunction | protein demethylase activity | 1.93e-04 | 32 | 181 | 4 | GO:0140457 | |
| GeneOntologyMolecularFunction | insulin-like growth factor receptor activity | 2.44e-04 | 3 | 181 | 2 | GO:0005010 | |
| GeneOntologyMolecularFunction | 2-oxoglutarate-dependent dioxygenase activity | 3.08e-04 | 65 | 181 | 5 | GO:0016706 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase activity | 3.61e-04 | 145 | 181 | 7 | GO:0004713 | |
| GeneOntologyMolecularFunction | omega peptidase activity | 3.76e-04 | 16 | 181 | 3 | GO:0008242 | |
| GeneOntologyMolecularFunction | protein kinase activity | EPHB6 STK36 EPHA6 CRIM1 PDGFRB MAP3K20 CDK14 LIMK1 IGF2R TIE1 CIITA GUCY2C PAK3 EIF2AK2 ALPK2 | 3.87e-04 | 600 | 181 | 15 | GO:0004672 |
| GeneOntologyMolecularFunction | glutaminase activity | 4.84e-04 | 4 | 181 | 2 | GO:0004359 | |
| GeneOntologyMolecularFunction | histone H3K36me/H3K36me2 demethylase activity | 4.84e-04 | 4 | 181 | 2 | GO:0140680 | |
| GeneOntologyMolecularFunction | demethylase activity | 6.68e-04 | 44 | 181 | 4 | GO:0032451 | |
| GeneOntologyMolecularFunction | polypeptide N-acetylgalactosaminyltransferase activity | 7.45e-04 | 20 | 181 | 3 | GO:0004653 | |
| GeneOntologyMolecularFunction | peptidyltransferase activity | 1.20e-03 | 6 | 181 | 2 | GO:0000048 | |
| GeneOntologyMolecularFunction | CoA carboxylase activity | 1.20e-03 | 6 | 181 | 2 | GO:0016421 | |
| GeneOntologyMolecularFunction | leukotriene-C(4) hydrolase | 1.20e-03 | 6 | 181 | 2 | GO:0002951 | |
| GeneOntologyMolecularFunction | histone H3K4me/H3K4me2/H3K4me3 demethylase activity | 1.20e-03 | 6 | 181 | 2 | GO:0034647 | |
| GeneOntologyMolecularFunction | calmodulin binding | 1.22e-03 | 230 | 181 | 8 | GO:0005516 | |
| GeneOntologyMolecularFunction | ligase activity, forming carbon-carbon bonds | 1.67e-03 | 7 | 181 | 2 | GO:0016885 | |
| GeneOntologyMolecularFunction | guanylyltransferase activity | 1.67e-03 | 7 | 181 | 2 | GO:0070568 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 1.99e-03 | 194 | 181 | 7 | GO:0016705 | |
| GeneOntologyMolecularFunction | dioxygenase activity | 1.99e-03 | 98 | 181 | 5 | GO:0051213 | |
| GeneOntologyMolecularFunction | transcription corepressor binding | 2.02e-03 | 59 | 181 | 4 | GO:0001222 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | EPHB6 STK36 EPHA6 CRIM1 PDGFRB MAP3K20 CDK14 LIMK1 IGF2R TIE1 CIITA GUCY2C PAK3 EIF2AK2 ALPK2 | 2.07e-03 | 709 | 181 | 15 | GO:0016773 |
| GeneOntologyMolecularFunction | leukotriene C4 gamma-glutamyl transferase activity | 2.21e-03 | 8 | 181 | 2 | GO:0103068 | |
| GeneOntologyMolecularFunction | histone H3K4 demethylase activity | 2.21e-03 | 8 | 181 | 2 | GO:0032453 | |
| GeneOntologyCellularComponent | postsynaptic density | SHANK1 DPYSL2 NRCAM DTNB ADGRB3 GRIN2A DCC ADD3 NSMF PAK3 PLCB4 ATP2B2 VDAC1 | 1.79e-04 | 451 | 183 | 13 | GO:0014069 |
| GeneOntologyCellularComponent | asymmetric synapse | SHANK1 DPYSL2 NRCAM DTNB ADGRB3 GRIN2A DCC ADD3 NSMF PAK3 PLCB4 ATP2B2 VDAC1 | 3.08e-04 | 477 | 183 | 13 | GO:0032279 |
| GeneOntologyCellularComponent | matrilin complex | 4.52e-04 | 4 | 183 | 2 | GO:0120216 | |
| GeneOntologyCellularComponent | postsynaptic specialization | SHANK1 DPYSL2 NRCAM DTNB ADGRB3 GRIN2A DCC ADD3 NSMF PAK3 PLCB4 ATP2B2 VDAC1 | 5.08e-04 | 503 | 183 | 13 | GO:0099572 |
| GeneOntologyCellularComponent | dendrite | SHANK1 EPHB6 DPYSL2 ADCY4 RELN EPHA6 MYO1D MYO5A MYO5B DTNB DOCK10 GLRX2 GRIN2A TRPM5 NSMF KCND1 PLCB4 ATP2B2 | 5.55e-04 | 858 | 183 | 18 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | SHANK1 EPHB6 DPYSL2 ADCY4 RELN EPHA6 MYO1D MYO5A MYO5B DTNB DOCK10 GLRX2 GRIN2A TRPM5 NSMF KCND1 PLCB4 ATP2B2 | 5.70e-04 | 860 | 183 | 18 | GO:0097447 |
| GeneOntologyCellularComponent | neuron to neuron synapse | SHANK1 DPYSL2 NRCAM DTNB ADGRB3 GRIN2A DCC ADD3 NSMF PAK3 PLCB4 ATP2B2 VDAC1 | 7.30e-04 | 523 | 183 | 13 | GO:0098984 |
| GeneOntologyCellularComponent | TRAMP complex | 7.49e-04 | 5 | 183 | 2 | GO:0031499 | |
| GeneOntologyCellularComponent | cluster of actin-based cell projections | 8.01e-04 | 223 | 183 | 8 | GO:0098862 | |
| Domain | TF_octamer | 8.37e-07 | 3 | 177 | 3 | IPR000972 | |
| Domain | FN3 | 6.93e-05 | 185 | 177 | 9 | SM00060 | |
| Domain | Glutaminase | 8.93e-05 | 2 | 177 | 2 | IPR015868 | |
| Domain | Glutaminase | 8.93e-05 | 2 | 177 | 2 | PF04960 | |
| Domain | GREB1 | 8.93e-05 | 2 | 177 | 2 | PF15782 | |
| Domain | GREB1 | 8.93e-05 | 2 | 177 | 2 | IPR028422 | |
| Domain | FN3 | 1.21e-04 | 199 | 177 | 9 | PS50853 | |
| Domain | FN3_dom | 1.75e-04 | 209 | 177 | 9 | IPR003961 | |
| Domain | JMJC | 2.28e-04 | 32 | 177 | 4 | PS51184 | |
| Domain | JmjC_dom | 2.28e-04 | 32 | 177 | 4 | IPR003347 | |
| Domain | Pkinase_Tyr | 2.31e-04 | 129 | 177 | 7 | PF07714 | |
| Domain | JmjC | 2.57e-04 | 33 | 177 | 4 | SM00558 | |
| Domain | - | 2.66e-04 | 3 | 177 | 2 | 3.40.710.10 | |
| Domain | Beta-lactam/transpept-like | 2.66e-04 | 3 | 177 | 2 | IPR012338 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 3.48e-04 | 138 | 177 | 7 | IPR001245 | |
| Domain | POU | 4.28e-04 | 16 | 177 | 3 | SM00352 | |
| Domain | POU_dom | 4.28e-04 | 16 | 177 | 3 | IPR000327 | |
| Domain | Pou | 4.28e-04 | 16 | 177 | 3 | PF00157 | |
| Domain | POU_1 | 4.28e-04 | 16 | 177 | 3 | PS00035 | |
| Domain | POU_2 | 4.28e-04 | 16 | 177 | 3 | PS00465 | |
| Domain | POU_3 | 4.28e-04 | 16 | 177 | 3 | PS51179 | |
| Domain | POU | 5.16e-04 | 17 | 177 | 3 | IPR013847 | |
| Domain | Carboxyl_trans | 5.29e-04 | 4 | 177 | 2 | PF01039 | |
| Domain | Matrilin_ccoil | 5.29e-04 | 4 | 177 | 2 | SM01279 | |
| Domain | COA_CT_CTER | 5.29e-04 | 4 | 177 | 2 | PS50989 | |
| Domain | COA_CT_NTER | 5.29e-04 | 4 | 177 | 2 | PS50980 | |
| Domain | - | 5.29e-04 | 4 | 177 | 2 | 1.20.5.30 | |
| Domain | Matrilin_ccoil | 5.29e-04 | 4 | 177 | 2 | PF10393 | |
| Domain | COA_CT_N | 5.29e-04 | 4 | 177 | 2 | IPR011762 | |
| Domain | COA_CT_C | 5.29e-04 | 4 | 177 | 2 | IPR011763 | |
| Domain | Matrilin_coiled-coil_trimer | 5.29e-04 | 4 | 177 | 2 | IPR019466 | |
| Domain | Carboxyl_trans | 5.29e-04 | 4 | 177 | 2 | IPR000022 | |
| Domain | Growth_fac_rcpt_ | 7.26e-04 | 156 | 177 | 7 | IPR009030 | |
| Domain | Myosin_S1_N | 8.76e-04 | 5 | 177 | 2 | IPR008989 | |
| Domain | fn3 | 9.07e-04 | 162 | 177 | 7 | PF00041 | |
| Domain | Dilute_dom | 1.31e-03 | 6 | 177 | 2 | IPR002710 | |
| Domain | DIL | 1.31e-03 | 6 | 177 | 2 | PF01843 | |
| Domain | DILUTE | 1.31e-03 | 6 | 177 | 2 | PS51126 | |
| Domain | DIL | 1.31e-03 | 6 | 177 | 2 | SM01132 | |
| Domain | JmjC | 1.46e-03 | 24 | 177 | 3 | PF02373 | |
| Domain | SAM | 1.50e-03 | 88 | 177 | 5 | SM00454 | |
| Domain | CUB | 1.59e-03 | 53 | 177 | 4 | PS01180 | |
| Domain | Ricin_B_lectin | 1.65e-03 | 25 | 177 | 3 | PF00652 | |
| Pubmed | SHANK1 EPHB6 TET2 DCHS2 DPYSL2 RELN CRIM1 NRCAM TTC28 MYO5A PDGFRB KDM5A BACH1 LARS1 ADGRB3 MSH3 ADD3 LIMK1 NSMF SCG2 GLS ASTN2 PBX1 CNOT2 USP47 ZNF292 | 4.95e-09 | 1285 | 184 | 26 | 35914814 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | PITPNM2 FNBP1 VIPR1 TRPM4 DPYSL2 ACACA EPHA6 MYO5A DTNB PCDH11Y MCCC2 LARP4 CDK14 INTS3 ARFGEF3 PPP2R2A SMG7 PAK3 RAB7A TMPRSS2 ASTN2 KDM2A PLCB4 GREB1 PBX1 CFAP69 TMEM181 | 2.40e-08 | 1489 | 184 | 27 | 28611215 |
| Pubmed | SHANK1 PITPNM2 RAB35 DPYSL2 NYAP2 ACACA NRCAM MYO5A BACH1 ADGRB3 GRIN2A MCCC2 AQP4 ADD3 ARFGEF3 UBXN4 SPHKAP GLS PAK3 RAB7A CNOT2 VDAC1 HDAC2 | 4.29e-08 | 1139 | 184 | 23 | 36417873 | |
| Pubmed | 2.06e-07 | 48 | 184 | 6 | 8884266 | ||
| Pubmed | Cloning and sequencing of POU-boxes expressed in mouse testis. | 5.80e-07 | 4 | 184 | 3 | 1970171 | |
| Pubmed | Functions of the POU domain genes Skn-1a/i and Tst-1/Oct-6/SCIP in epidermal differentiation. | 5.80e-07 | 4 | 184 | 3 | 9242494 | |
| Pubmed | Angiopoietin-1 Is Required for Vortex Vein and Choriocapillaris Development in Mice. | 7.28e-07 | 14 | 184 | 4 | 36172864 | |
| Pubmed | 1.71e-06 | 17 | 184 | 4 | 19690890 | ||
| Pubmed | 2.76e-06 | 19 | 184 | 4 | 15184386 | ||
| Pubmed | Signals transduced by Ca(2+)/calcineurin and NFATc3/c4 pattern the developing vasculature. | 2.85e-06 | 42 | 184 | 5 | 11439183 | |
| Pubmed | Production of type I IFN sensitizes macrophages to cell death induced by Listeria monocytogenes. | 2.88e-06 | 6 | 184 | 3 | 12444163 | |
| Pubmed | 4.04e-06 | 45 | 184 | 5 | 25979088 | ||
| Pubmed | Extracellular matrix protein Matrilin-4 regulates stress-induced HSC proliferation via CXCR4. | 5.02e-06 | 7 | 184 | 3 | 27573814 | |
| Pubmed | A common variant in DRD3 receptor is associated with autism spectrum disorder. | 5.70e-06 | 128 | 184 | 7 | 19058789 | |
| Pubmed | Ascending Vasa Recta Are Angiopoietin/Tie2-Dependent Lymphatic-Like Vessels. | 6.21e-06 | 23 | 184 | 4 | 29237738 | |
| Pubmed | 7.42e-06 | 24 | 184 | 4 | 31740596 | ||
| Pubmed | 7.42e-06 | 24 | 184 | 4 | 20371769 | ||
| Pubmed | 8.00e-06 | 8 | 184 | 3 | 27065334 | ||
| Pubmed | 8.00e-06 | 8 | 184 | 3 | 37315734 | ||
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | DPYSL2 ACACA MYO1D MYO5A KDM5A LARP4 PPP2R2A SMG7 SERPINB2 KDM2A ZNF281 NNT EXOSC4 PRRC2B ZNF292 | 8.05e-06 | 724 | 184 | 15 | 36232890 |
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | LZTR1 TMC1 CRIM1 MYO5A MATN1 RALGPS2 LARS1 CDH23 GRIN2A CDK14 GRM8 HIBADH IFNAR1 NSMF RASSF1 KDM7A PLSCR2 XKRX ATP2B2 PRRC2B | 1.06e-05 | 1242 | 184 | 20 | 30973865 |
| Pubmed | Genome-wide association study of smoking initiation and current smoking. | 1.20e-05 | 9 | 184 | 3 | 19268276 | |
| Pubmed | Dysmorphogenesis of kidney cortical peritubular capillaries in angiopoietin-2-deficient mice. | 1.20e-05 | 9 | 184 | 3 | 15579434 | |
| Pubmed | Genetic dissection of tie pathway in mouse lymphatic maturation and valve development. | 1.20e-05 | 9 | 184 | 3 | 24764452 | |
| Pubmed | 1.70e-05 | 10 | 184 | 3 | 21768377 | ||
| Pubmed | Protocadherin 12 deficiency alters morphogenesis and transcriptional profile of the placenta. | 1.70e-05 | 10 | 184 | 3 | 18477666 | |
| Pubmed | 1.70e-05 | 10 | 184 | 3 | 12221099 | ||
| Pubmed | Association of gene variants with incident myocardial infarction in the Cardiovascular Health Study. | 1.99e-05 | 62 | 184 | 5 | 17975119 | |
| Pubmed | 2.11e-05 | 105 | 184 | 6 | 9628581 | ||
| Pubmed | Crim1 has cell-autonomous and paracrine roles during embryonic heart development. | 2.13e-05 | 31 | 184 | 4 | 26821812 | |
| Pubmed | Gene variants associated with ischemic stroke: the cardiovascular health study. | 2.15e-05 | 63 | 184 | 5 | 19023099 | |
| Pubmed | Developmental regulation of yolk sac hematopoiesis by Kruppel-like factor 6. | 2.33e-05 | 11 | 184 | 3 | 16234353 | |
| Pubmed | Formation of persistent hyperplastic primary vitreous in ephrin-A5-/- mice. | 2.33e-05 | 11 | 184 | 3 | 24550361 | |
| Pubmed | Endoglin is required in Pax3-derived cells for embryonic blood vessel formation. | 2.33e-05 | 11 | 184 | 3 | 26481065 | |
| Pubmed | The netrin receptor UNC5B mediates guidance events controlling morphogenesis of the vascular system. | 2.33e-05 | 11 | 184 | 3 | 15510105 | |
| Pubmed | SHANK1 PITPNM2 DPYSL2 ADCY4 NRCAM MYO1D MYO5A MYO5B LARS1 GRIN2A AQP4 ADD3 PPP2R2A ITSN2 RAB7A UQCRFS1 ATP2B2 MTCH2 PRRC2B VDAC1 DNAH11 | 2.50e-05 | 1431 | 184 | 21 | 37142655 | |
| Pubmed | EPHB6 CUL1 RELN NRCAM CDK14 HIBADH ABCB4 LIMK1 KCNH2 SKAP2 DNAH11 | 2.56e-05 | 441 | 184 | 11 | 12853948 | |
| Pubmed | Genetic mapping of the human and mouse phospholipase C genes. | 2.75e-05 | 33 | 184 | 4 | 8672127 | |
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 11423214 | ||
| Pubmed | Human Oct-1L isoform has tissue-specific expression pattern similar to Oct-2. | 2.78e-05 | 2 | 184 | 2 | 12663137 | |
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 21211561 | ||
| Pubmed | Revisiting the human polypeptide GalNAc-T1 and T13 paralogs. | 2.78e-05 | 2 | 184 | 2 | 27913570 | |
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 15831936 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 31771949 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 17669570 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 24276018 | ||
| Pubmed | Regulation of mycobacterial infection by macrophage Gch1 and tetrahydrobiopterin. | 2.78e-05 | 2 | 184 | 2 | 30573728 | |
| Pubmed | Exome-wide Association Study Identifies GREB1L Mutations in Congenital Kidney Malformations. | 2.78e-05 | 2 | 184 | 2 | 29100090 | |
| Pubmed | Adding efficiency: the role of the CAN ion channels TRPM4 and TRPM5 in pancreatic islets. | 2.78e-05 | 2 | 184 | 2 | 21099334 | |
| Pubmed | Glutaminase isoforms expression switches microRNA levels and oxidative status in glioblastoma cells. | 2.78e-05 | 2 | 184 | 2 | 33610185 | |
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 22349263 | ||
| Pubmed | A requirement for Gch1 and tetrahydrobiopterin in embryonic development. | 2.78e-05 | 2 | 184 | 2 | 25557619 | |
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 31269442 | ||
| Pubmed | Arginine-nitric oxide-polyamine metabolism in periodontal disease. | 2.78e-05 | 2 | 184 | 2 | 20831369 | |
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 19291698 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 12144930 | ||
| Pubmed | Mixed tailing by TENT4A and TENT4B shields mRNA from rapid deadenylation. | 2.78e-05 | 2 | 184 | 2 | 30026317 | |
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 9556620 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 29216297 | ||
| Pubmed | Comparison of functional properties of the Ca2+-activated cation channels TRPM4 and TRPM5 from mice. | 2.78e-05 | 2 | 184 | 2 | 15670874 | |
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 10984423 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 8156594 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 22261923 | ||
| Pubmed | TRPM5 is a voltage-modulated and Ca(2+)-activated monovalent selective cation channel. | 2.78e-05 | 2 | 184 | 2 | 12842017 | |
| Pubmed | Temporal and spatial resolution of type I and III interferon responses in vivo. | 2.78e-05 | 2 | 184 | 2 | 20573823 | |
| Pubmed | A functional study of plasma-membrane calcium-pump isoform 2 mutants causing digenic deafness. | 2.78e-05 | 2 | 184 | 2 | 17234811 | |
| Pubmed | Pathogenesis of Dugbe virus infection in wild-type and interferon-deficient mice. | 2.78e-05 | 2 | 184 | 2 | 16760403 | |
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 28612045 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 37582836 | ||
| Pubmed | Co-expression of glutaminase K and L isoenzymes in human tumour cells. | 2.78e-05 | 2 | 184 | 2 | 15496140 | |
| Pubmed | Molecular cloning, sequencing and expression studies of the human breast cancer cell glutaminase. | 2.78e-05 | 2 | 184 | 2 | 10620514 | |
| Pubmed | Differential dimer activities of the transcription factor Oct-1 by DNA-induced interface swapping. | 2.78e-05 | 2 | 184 | 2 | 11583619 | |
| Pubmed | Modification of human hearing loss by plasma-membrane calcium pump PMCA2. | 2.78e-05 | 2 | 184 | 2 | 15829536 | |
| Pubmed | The origin and evolution of human glutaminases and their atypical C-terminal ankyrin repeats. | 2.78e-05 | 2 | 184 | 2 | 28526749 | |
| Pubmed | Full-length human glutaminase in complex with an allosteric inhibitor. | 2.78e-05 | 2 | 184 | 2 | 22049910 | |
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 35141006 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 37924851 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 10066793 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 19467240 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 32559291 | ||
| Pubmed | Identification of novel single-stranded DNA binding proteins recognizing octamer motif. | 2.78e-05 | 2 | 184 | 2 | 8185580 | |
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 30716103 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 11130979 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 32224228 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 28739660 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 16051816 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 17955477 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 18758465 | ||
| Pubmed | Expression of Gls and Gls2 glutaminase isoforms in astrocytes. | 2.78e-05 | 2 | 184 | 2 | 25297978 | |
| Pubmed | mdfw: a deafness susceptibility locus that interacts with deaf waddler (dfw). | 2.78e-05 | 2 | 184 | 2 | 9325047 | |
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 33205915 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 23792079 | ||
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 19279235 | ||
| Pubmed | TRPM4 and TRPM5 are both required for normal signaling in taste receptor cells. | 2.78e-05 | 2 | 184 | 2 | 29311301 | |
| Pubmed | Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B cells. | 2.78e-05 | 2 | 184 | 2 | 22225880 | |
| Pubmed | 2.78e-05 | 2 | 184 | 2 | 31901078 | ||
| Pubmed | Early embryonic expression of murine coagulation system components. | 3.11e-05 | 34 | 184 | 4 | 11154109 | |
| Pubmed | A neurogenomics approach to gene expression analysis in the developing brain. | 3.60e-05 | 170 | 184 | 7 | 15582152 | |
| Pubmed | EPHB6 CUL1 TENT4B GALNT1 TENT4A GALNT12 CPM GGT2P GALNT13 DMXL1 KCNH2 KDM2A HDAC2 DNAH11 | 3.78e-05 | 730 | 184 | 14 | 34857952 | |
| Pubmed | FNBP1 LPCAT1 NYAP2 MYO1D TTC28 INTS3 TBL3 GLS ITSN2 ZNF281 PRRC2B USP47 DNAH11 | 3.90e-05 | 638 | 184 | 13 | 31182584 | |
| GeneFamily | Fibronectin type III domain containing | 2.70e-05 | 160 | 135 | 8 | 555 | |
| GeneFamily | Myosins, class V | 1.65e-04 | 3 | 135 | 2 | 1100 | |
| GeneFamily | Polypeptide N-acetylgalactosaminyltransferases | 4.23e-04 | 20 | 135 | 3 | 433 | |
| GeneFamily | Immunoglobulin like domain containing | 6.21e-04 | 193 | 135 | 7 | 594 | |
| GeneFamily | POU class homeoboxes and pseudogenes | 6.46e-04 | 23 | 135 | 3 | 523 | |
| GeneFamily | PHD finger proteins|Lysine demethylases | 7.35e-04 | 24 | 135 | 3 | 485 | |
| GeneFamily | Non-canonical poly(A) polymerases | 1.13e-03 | 7 | 135 | 2 | 1318 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.33e-03 | 161 | 135 | 6 | 593 | |
| GeneFamily | Histone deacetylases, class I|EMSY complex|NuRD complex|SIN3 histone deacetylase complex | 3.48e-03 | 12 | 135 | 2 | 1243 | |
| GeneFamily | CD molecules|Gamma-glutamyltransferases | 4.09e-03 | 13 | 135 | 2 | 564 | |
| GeneFamily | Sterile alpha motif domain containing | 4.27e-03 | 88 | 135 | 4 | 760 | |
| GeneFamily | Fibronectin type III domain containing|Sterile alpha motif domain containing|EPH receptors | 4.75e-03 | 14 | 135 | 2 | 1095 | |
| Coexpression | GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH1_UP | 1.12e-05 | 199 | 182 | 9 | M4521 | |
| Coexpression | GSE21670_UNTREATED_VS_TGFB_TREATED_CD4_TCELL_DN | 1.12e-05 | 199 | 182 | 9 | M7472 | |
| CoexpressionAtlas | B cells, B.Fo.Sp, IgD+ IgM+ CD45R+ CD24+ CD19+ AA4.1- CD23+, Spleen, avg-3 | FOXO1 LPCAT1 MYO5A PECAM1 RALGPS2 SIDT1 POU2F2 CPM ADD3 DMXL1 CIITA ITSN2 KDM7A XKRX | 1.36e-06 | 345 | 178 | 14 | GSM538201_500 |
| CoexpressionAtlas | CD positive, CD19 Control, 19+ 4- 8-, Spleen, avg-6 | FOXO1 LPCAT1 MYO5A PECAM1 RALGPS2 SIDT1 POU2F1 POU2F2 CPM DMXL1 CIITA ITSN2 XKRX | 6.05e-06 | 339 | 178 | 13 | GSM403988_500 |
| CoexpressionAtlas | CD positive, CD4 Test NA, 4+8-B220-, Spleen, avg-1 | EPHB6 FOXO1 PITPNM2 VIPR1 CRIM1 TTC28 PECAM1 SIDT1 IRF6 CPM ADD3 ZNF281 XKRX | 1.05e-05 | 357 | 178 | 13 | GSM403986_500 |
| CoexpressionAtlas | B cells, B.FrF.BM, CD19+ IgM+ AA4.1- HSA+, Bone marrow, avg-3 | FOXO1 LPCAT1 MYO5A PECAM1 RALGPS2 SIDT1 POU2F2 CPM ADD3 DMXL1 CIITA KDM7A XKRX | 1.41e-05 | 367 | 178 | 13 | GSM399440_500 |
| CoexpressionAtlas | B cells, B.Fo.PC, IgD+ IgM+ CD19+ CD43- CD5- CD23+, Peritoneal Cavity, avg-3 | FOXO1 LPCAT1 MYO5A RALGPS2 SIDT1 POU2F2 CPM ADD3 DMXL1 CIITA ITSN2 XKRX | 4.41e-05 | 352 | 178 | 12 | GSM538198_500 |
| CoexpressionAtlas | CD positive, CD4 Test JS, 4+8-B220-, Spleen, avg-3 | EPHB6 FOXO1 PITPNM2 VIPR1 CRIM1 TTC28 PECAM1 SIDT1 IRF6 CPM ADD3 XKRX | 5.33e-05 | 359 | 178 | 12 | GSM404000_500 |
| CoexpressionAtlas | kidney_adult_Mesangium_Meis_top-relative-expression-ranked_100 | 6.15e-05 | 81 | 178 | 6 | gudmap_kidney_adult_Mesangium_Meis_100 | |
| CoexpressionAtlas | kidney_adult_RenCorpuscGlomer_k-means-cluster#1_top-relative-expression-ranked_500 | 6.15e-05 | 81 | 178 | 6 | gudmap_kidney_adult_RenCorpuscGlomer_k1_500 | |
| CoexpressionAtlas | alpha beta T cells, T.4SP24int.Th, 4+ 8- TCRhi 24int, Thymus, avg-3 | EPHB6 FOXO1 PITPNM2 VIPR1 RALGPS2 CPM SLC15A1 KCNH2 DNAI4 ZNF281 XKRX | 9.55e-05 | 324 | 178 | 11 | GSM399373_500 |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2+.Sp.TCRbko, TCRd+ Vg2+ CD44-, Spleen, avg-3 | EPHB6 FOXO1 PITPNM2 VIPR1 CRIM1 TTC28 PDGFRB SIDT1 CPM ADD3 LIMK1 IGF2R | 1.11e-04 | 388 | 178 | 12 | GSM605790_500 |
| CoexpressionAtlas | alpha beta T cells, T.4Nve.LN, 4+ 8- 25- 62Lhi 44lo, Lymph Node, avg-3 | EPHB6 FOXO1 PITPNM2 VIPR1 CRIM1 TTC28 PECAM1 SIDT1 CPM ADD3 XKRX | 1.31e-04 | 336 | 178 | 11 | GSM538374_500 |
| CoexpressionAtlas | alpha beta T cells, T.4.TI.B16, 4+ 8- TCR+ 45+, B16 Melanoma Tumor, avg-3 | EPHB6 FOXO1 PITPNM2 VIPR1 CRIM1 TTC28 PECAM1 SIDT1 CPM ADD3 XKRX | 1.38e-04 | 338 | 178 | 11 | GSM605763_500 |
| CoexpressionAtlas | CD positive, CD4 Test DB, 4+8-B220-, Spleen, avg-1 | EPHB6 FOXO1 PITPNM2 VIPR1 CRIM1 TTC28 PECAM1 SIDT1 CPM ADD3 XKRX | 1.38e-04 | 338 | 178 | 11 | GSM403987_500 |
| CoexpressionAtlas | alpha beta T cells, T.4Nve.Sp, 4+ 8- 25- 62Lhi 44lo, Spleen, avg-4 | EPHB6 FOXO1 VIPR1 CRIM1 TTC28 RALGPS2 SIDT1 CPM ADD3 ZNF281 XKRX | 1.42e-04 | 339 | 178 | 11 | GSM538382_500 |
| CoexpressionAtlas | B cells, B.Fo.LN, CD19+ CD45R+ CD23+ CD21/35+, Lymph Node, avg-2 | FOXO1 PECAM1 RALGPS2 SIDT1 POU2F1 POU2F2 CPM DMXL1 CIITA PLCG2 XKRX | 1.42e-04 | 339 | 178 | 11 | GSM777019_500 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.65e-04 | 234 | 178 | 9 | gudmap_developingGonad_e18.5_epididymis_1000_k5 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2-.Sp.TCRbko, TCRd+ Vg2- CD44-, Spleen, avg-3 | EPHB6 FOXO1 PITPNM2 VIPR1 CRIM1 TTC28 PDGFRB SIDT1 CPM ADD3 LIMK1 IGF2R | 1.66e-04 | 405 | 178 | 12 | GSM605796_500 |
| CoexpressionAtlas | B cells, B.T3.Sp, IgD+ IgM+ CD45R+ CD24+ CD19+ AA4.1+ CD23+, Spleen, avg-3 | FOXO1 MYO5A PECAM1 RALGPS2 POU2F2 CPM ADD3 DMXL1 CIITA ITSN2 XKRX | 2.45e-04 | 361 | 178 | 11 | GSM538219_500 |
| CoexpressionAtlas | alpha beta T cells, T.4FP3-.Sp, 4+ 8- GFP- 44lo, Spleen, avg-3 | EPHB6 FOXO1 PITPNM2 VIPR1 CRIM1 TTC28 PECAM1 SIDT1 CPM ADD3 XKRX | 2.63e-04 | 364 | 178 | 11 | GSM605766_500 |
| CoexpressionAtlas | alpha beta T cells, T.4SP24-.Th, 4+ 8- TCRhi 24-/lo, Thymus, avg-3 | EPHB6 FOXO1 PITPNM2 VIPR1 TTC28 PECAM1 SIDT1 CPM ADD3 SLC15A1 XKRX | 2.69e-04 | 365 | 178 | 11 | GSM399370_500 |
| CoexpressionAtlas | alpha beta T cells, T.4SP69+.Th, 4+ 8- TCRhi 69+, Thymus, avg-3 | EPHB6 FOXO1 PITPNM2 VIPR1 RALGPS2 CPM SLC15A1 KCNH2 DNAI4 ZNF281 XKRX | 2.69e-04 | 365 | 178 | 11 | GSM399376_500 |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | TRHDE NRCAM RALGPS2 ADGRB3 DCC CDK14 RND3 C1R COL14A1 PBX1 CFAP69 | 5.37e-10 | 194 | 183 | 11 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 |
| ToppCell | PCW_07-8.5-Epithelial|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.34e-09 | 194 | 183 | 10 | f63ceedb88a9abc8644ee94adfd541e7817c1e3a | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.75e-08 | 182 | 183 | 9 | a20017b6a4f9a6a29e090e4dbd7c02ed1495bd50 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.41e-08 | 184 | 183 | 9 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.41e-08 | 184 | 183 | 9 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.41e-08 | 184 | 183 | 9 | 30ca56d64c961127e26122613e35aa2b46fde2df | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.41e-08 | 184 | 183 | 9 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_CA4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.91e-08 | 188 | 183 | 9 | ee572246e0c2f41bdbc29a03edc67b831af95c09 | |
| ToppCell | COVID-19-Endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 9.76e-08 | 190 | 183 | 9 | 9fbd92cd6d4683b2490504d29c43cf42020433d4 | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.02e-07 | 191 | 183 | 9 | f229abf69a1217194f74b0502486907e07dba989 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_alveolar-distal-epi_CTGF^high_distal_(3)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.17e-07 | 194 | 183 | 9 | c5ef4ff73b4e51530656002e3a2fb7264cdf533d | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.17e-07 | 194 | 183 | 9 | f95c8dc242c9aebcadfe61b1ed033349cb7e5a88 | |
| ToppCell | Tracheal-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.51e-07 | 200 | 183 | 9 | 5ec31c1be6bcc4124e1489d136570f3de33cc2e9 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-PAX6-CDH12-L1-2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.51e-07 | 200 | 183 | 9 | ead9eb579bb25fde05fc15602e3d05ab6617f7ac | |
| ToppCell | Control_saline-Endothelial-Endothelial-Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 1.51e-07 | 200 | 183 | 9 | 3b97920e1e6e2f09ddba2a861baa9c00c2970f4c | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-PAX6-CDH12|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.51e-07 | 200 | 183 | 9 | c74bc12e13d002dedaaf75a2244ec111e47524e1 | |
| ToppCell | mild-B_intermediate|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.51e-07 | 200 | 183 | 9 | fe815824e9e4be3f3db73610e3814a7fd533da65 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-Treg_cell_4|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.53e-07 | 154 | 183 | 8 | a90c4c45685eae8d21d03479cfd5a23f6ed3ca07 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.37e-07 | 170 | 183 | 8 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.13e-07 | 173 | 183 | 8 | 869da6a65d1b9b7529c666ec44e3c8ddec2ea408 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.13e-07 | 173 | 183 | 8 | 0672bd8a4a9d18af343d01f09253fb3388896c10 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.13e-07 | 173 | 183 | 8 | 870e091ec30be01a900e1cb8b9ef1880e3b7b50d | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.68e-07 | 175 | 183 | 8 | 1ea6cf9da26601646f57fa14d558a5e9e1f0b345 | |
| ToppCell | facs-Marrow-B-cells-24m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.68e-07 | 175 | 183 | 8 | 887e75fc90e59a6394d62f3c048a9cfdf6707725 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC2_(MADCAM1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.28e-07 | 177 | 183 | 8 | 76f5df101c693e5fa61554244d877fc8169ee66f | |
| ToppCell | COPD-Epithelial-PNEC|Epithelial / Disease state, Lineage and Cell class | 7.93e-07 | 179 | 183 | 8 | 988d0853c391da1e5004f73f3678047418d3f6d3 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_HNRNPA1P46|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.27e-07 | 180 | 183 | 8 | 8923a42a6db9c6e9f3ce2ca9530e620dfea700ba | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Fam19a1_Tmem182|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.28e-07 | 124 | 183 | 7 | 690595d710b57b7cff8029a3bb06a8dd7e3c03c1 | |
| ToppCell | COVID-19-kidney-CD-IC-B|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.99e-07 | 182 | 183 | 8 | ee6a8c356bbbdae55e4ea858337e079491f9f4aa | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 9.37e-07 | 183 | 183 | 8 | c5b10571599dc26476170b54b53f09c23e6b3117 | |
| ToppCell | COVID-19-Fibroblasts-Adventitial_FB|COVID-19 / group, cell type (main and fine annotations) | 1.02e-06 | 185 | 183 | 8 | a5aebf2b9b05b550d021272731d68af9a6b1229d | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.06e-06 | 186 | 183 | 8 | b45cce768e4bf91da194fd9660cab7520dfb15ac | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.06e-06 | 186 | 183 | 8 | 20340a5b5cc7f07386498a4ef937d6fbc9e347c4 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-interneuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-06 | 187 | 183 | 8 | 1b2fdbfb1ce3f19795dfc4b1da5a94f4b057ec41 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 1.15e-06 | 188 | 183 | 8 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.19e-06 | 189 | 183 | 8 | 7659c7bbd58ee959a159294fb8d17317bbcc5681 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 1.19e-06 | 189 | 183 | 8 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.24e-06 | 190 | 183 | 8 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | COVID-19-Endothelial_cells-Endothelial_cells_(general)|COVID-19 / group, cell type (main and fine annotations) | 1.24e-06 | 190 | 183 | 8 | 812e11314c76c0179fbe5a9bea29b41ce5cbc93d | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.24e-06 | 190 | 183 | 8 | 562ee3b025c29edf07b8b344323edb49d82f1c7e | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.24e-06 | 190 | 183 | 8 | 5681c211baeed4af82a2bbc13420f6a7b487581c | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.24e-06 | 190 | 183 | 8 | f5fb989afabb49d64d91324570cd8c80a4b9e67d | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.29e-06 | 191 | 183 | 8 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | Fetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.29e-06 | 191 | 183 | 8 | 1de0bdfd13bd930691564c2673f2e66393bc0255 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_STALK-Flt1_2|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.33e-06 | 133 | 183 | 7 | 29b0c2c682c6b97823e7d8d8ba1f5114044b30ba | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.34e-06 | 192 | 183 | 8 | ee085e04d5dcfb657522484ed20b8c1ddeccfe0c | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.34e-06 | 192 | 183 | 8 | 56b021c297a21dff357531f21e2464f85186106d | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.34e-06 | 192 | 183 | 8 | 25378b5e4b0cea8415ff125783511fc25a56fc00 | |
| ToppCell | COVID-19-kidney-AQP1+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.34e-06 | 192 | 183 | 8 | 27ff3621e177e7932dd44dd6baa81551ea75a874 | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.34e-06 | 192 | 183 | 8 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.40e-06 | 193 | 183 | 8 | af6ec2c2ba92aef3e41531c3c7215b3300437bd9 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 1.40e-06 | 193 | 183 | 8 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.40e-06 | 193 | 183 | 8 | 2483bb7f398e4fa0ef09c8bd584ed25703853f03 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.40e-06 | 193 | 183 | 8 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | CF-Lymphoid-B_cell|Lymphoid / Disease state, Lineage and Cell class | 1.40e-06 | 193 | 183 | 8 | 7ebf20344a9a154fd2cffa281526867fcf0aded3 | |
| ToppCell | Children_(3_yrs)-Endothelial-capillary_endothelial_cell_(Cap1)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.45e-06 | 194 | 183 | 8 | 71ac69cdf7a08ca3ddfb5b492b14ac56b6cd5e5d | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_airway-epi_proximal_secretory_(0)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.45e-06 | 194 | 183 | 8 | b19e16a76d7342ff9a665d19c9151652916f17d4 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 1.51e-06 | 195 | 183 | 8 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 1.51e-06 | 195 | 183 | 8 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | Adult-Immune-monocyte-D231|Adult / Lineage, Cell type, age group and donor | 1.51e-06 | 195 | 183 | 8 | ea24da6fea1487acb1e56c28c0649858cc0a12bd | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.57e-06 | 196 | 183 | 8 | 023312af38f816a44b407e0daa32590d953caf99 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.57e-06 | 196 | 183 | 8 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | COVID-19-Myeloid-Monocytes|COVID-19 / group, cell type (main and fine annotations) | 1.57e-06 | 196 | 183 | 8 | 04d710267658ea5601ae2cfb4ed5acb8a29bd8a1 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.57e-06 | 196 | 183 | 8 | b8f89a50114932c08fc5daac4b549adfe9df8e66 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-B-B_plasma-B_plasma_IgG|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.57e-06 | 196 | 183 | 8 | fd18a9ae8401121ae276adff1a85d5f938e2df91 | |
| ToppCell | Endothelial|World / Lineage, Cell type, age group and donor | 1.57e-06 | 196 | 183 | 8 | 96c6d78482a130ce4e29f6629972a06d10d7530e | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.57e-06 | 196 | 183 | 8 | d0ff1082898d2db47c88d2678466514e9e9193d3 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 1.63e-06 | 197 | 183 | 8 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | nucseq-Endothelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.63e-06 | 197 | 183 | 8 | ebf9be068eaa658493fa7884fd19f34642922acb | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-B-B_cell-B_mature|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.69e-06 | 198 | 183 | 8 | 4aa4ae2571effcfb6eb6923f7173cd3e7e4af9ef | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.69e-06 | 198 | 183 | 8 | 9ab0db78394e730f6866b2db80047149024ad5f6 | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.69e-06 | 198 | 183 | 8 | fc4b7c3ad52bc5c8b40fa04a156bfbb58afa2872 | |
| ToppCell | control-B_intermediate|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.69e-06 | 198 | 183 | 8 | e24345c8cec8c21f7b5163b7326ba8f83a587ce3 | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.69e-06 | 198 | 183 | 8 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.69e-06 | 198 | 183 | 8 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.69e-06 | 198 | 183 | 8 | b3a020522e064bb61949d38e442f24026e339364 | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_lymphatic-Endothelia_Lymphatic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.69e-06 | 198 | 183 | 8 | e47d0e2c6353315c85d7007742bb16b0f05795ed | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-B-B_plasma-B_plasma_IgA|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.75e-06 | 199 | 183 | 8 | 1bb02f41f3cc76a28581e38b0ca4c36b930b85b4 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-B-B_plasma|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.75e-06 | 199 | 183 | 8 | 2f60682f1b82918a65e8851e99c9e3398845b62f | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.75e-06 | 199 | 183 | 8 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-B|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.75e-06 | 199 | 183 | 8 | 58242d78517c05fa367a7c6edac57ef79107453c | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.75e-06 | 199 | 183 | 8 | 7ed541309808f15d65a9c4b26be2050e077539e6 | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.75e-06 | 199 | 183 | 8 | 6a2943a23fdd2ec814662db7c21a0d6804a6cbbc | |
| ToppCell | COVID-19-COVID-19_Convalescent-Lymphocyte-B-B_intermediate|COVID-19_Convalescent / Disease, condition lineage and cell class | 1.82e-06 | 200 | 183 | 8 | fdc0df661a34e0db3279334bdeebfdf60c85ef41 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Artery|Control_saline / Treatment groups by lineage, cell group, cell type | 1.82e-06 | 200 | 183 | 8 | 65b71f1e8da5c3750fcd0a2e66d9ef3125a3f78a | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Artery|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.82e-06 | 200 | 183 | 8 | ac9ead34afa14067171833f5c277eaf06db7b02e | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuronal-Intermediate|2m / Sample Type, Dataset, Time_group, and Cell type. | 1.82e-06 | 200 | 183 | 8 | 2a635694844ddabcd98462c5636a6f41a3f08a46 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_granulocytic|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.35e-06 | 159 | 183 | 7 | 7b6370c9567da7d40541c6e243efa704ed7e90ae | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_granulocytic-mast_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.35e-06 | 159 | 183 | 7 | ecd1daa33549541aee3bf4e139ab6732efc8e74c | |
| ToppCell | COPD-Epithelial-PNEC|World / Disease state, Lineage and Cell class | 4.53e-06 | 160 | 183 | 7 | cdea93317b0ebb801ddbe73bca6149ce2c727f16 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Cplx3|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 4.55e-06 | 104 | 183 | 6 | b5ca6e589f414e549f4990fe334d4ee54829b298 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-Tuft-related-Tuft|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.72e-06 | 161 | 183 | 7 | f5df8c6a340d5026726804b103e32137f363ca40 | |
| ToppCell | facs-Aorta-Heart-3m-Mesenchymal-fibrocyte|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.55e-06 | 165 | 183 | 7 | 8a52f2dbcbd2bc1662b5e3fac381463fdcc3bf14 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.78e-06 | 166 | 183 | 7 | 7a45785a40b7425f97be67bab1c5ceb69b2bd85a | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.78e-06 | 166 | 183 | 7 | bbd382812f8a84a5d99888de2d7cca3a8b5e4695 | |
| ToppCell | facs-Heart-RA-18m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.25e-06 | 168 | 183 | 7 | 06dc5b2d356d3a9454b10bba6f3b9ead2a0a7d46 | |
| ToppCell | Control-B_cells-Activated_B_cells|Control / group, cell type (main and fine annotations) | 6.25e-06 | 168 | 183 | 7 | a7159a35fe37f8c241cf8d391debe271e0698105 | |
| ToppCell | facs-Heart-RA-18m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.25e-06 | 168 | 183 | 7 | 1002f058a340763e3d8de0bd1f0547a903526ec6 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.50e-06 | 169 | 183 | 7 | b6b5bb6408c1305a00719e1b88a5e1202081faf3 | |
| ToppCell | droplet-Thymus-nan-21m-Myeloid-professional_antigen_presenting_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.75e-06 | 170 | 183 | 7 | 29deb285d5a82c0abcc108012ca42f4b4b4d9e19 | |
| Drug | Loperamide hydrochloride [34552-83-5]; Down 200; 7.8uM; MCF7; HT_HG-U133A | CRIM1 GOSR1 SMG7 KCNH2 RASSF1 GLCE GLS TMPRSS2 ASTN2 SERPINA5 | 4.84e-06 | 198 | 183 | 10 | 1533_DN |
| Drug | Tiratricol, 3,3',5-triiodothyroacetic acid [51-24-1]; Up 200; 6.4uM; MCF7; HT_HG-U133A | VIPR1 RELN DTNB PCDHGA1 RALGPS2 ADGRB3 DOCK10 POU2F2 GRM8 CIITA | 4.84e-06 | 198 | 183 | 10 | 2259_UP |
| Drug | Pizotifen malate [5189-11-7]; Down 200; 9.4uM; MCF7; HT_HG-U133A | TRPM4 RAB35 NRCAM RANBP3 LIMK1 KCNH2 GLS TMPRSS2 ASTN2 PGBD5 | 5.06e-06 | 199 | 183 | 10 | 6513_DN |
| Drug | potassium | TRPM4 ADCY4 GLS2 MYO5A DTNB GCH1 GRIN2A ODC1 GRM8 F5 AQP4 TRPM5 KCND1 GUCY2C KCNH2 SCG2 GLS SLC36A3 PLCB4 PLCG2 NOS2 ATP2B2 ALPK2 | 6.60e-06 | 1008 | 183 | 23 | CID000000813 |
| Disease | Autistic Disorder | SHANK1 RELN LZTR1 NRCAM MYO1D PECAM1 GRIN2A GRM8 AQP4 ASTN2 TBR1 NOS2 ZNF292 | 9.95e-09 | 261 | 182 | 13 | C0004352 |
| Disease | immune system disease (implicated_via_orthology) | 2.31e-07 | 3 | 182 | 3 | DOID:2914 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | SHANK1 EPHB6 TET2 DPYSL2 ACACA NRCAM GALNT12 GRIN2A ODC1 CUBN DCC ADAMTSL3 F5 ABCB4 ARAP3 GUCY2C KDM2A ZNF292 | 4.00e-07 | 702 | 182 | 18 | C0009402 |
| Disease | Colorectal Neoplasms | TET2 NRCAM GALNT12 GRIN2A ODC1 DCC ABCB4 GUCY2C KDM2A ZNF292 | 9.37e-06 | 277 | 182 | 10 | C0009404 |
| Disease | Prostatic Neoplasms | FOXO1 TET2 TRPM4 STAB2 PCDH11Y MATN4 MSH3 PPP2R2A IGF2R ITSN2 TMPRSS2 GREB1 EIF2AK2 ZNF292 | 3.12e-05 | 616 | 182 | 14 | C0033578 |
| Disease | Malignant neoplasm of prostate | FOXO1 TET2 TRPM4 STAB2 PCDH11Y MATN4 MSH3 PPP2R2A IGF2R ITSN2 TMPRSS2 GREB1 EIF2AK2 ZNF292 | 3.12e-05 | 616 | 182 | 14 | C0376358 |
| Disease | Ischemic stroke | DCHS2 GALNT1 TMEM126B ADAMTSL3 F5 GALNT13 ASTN2 COL14A1 PLCB4 DNAH11 | 3.59e-05 | 324 | 182 | 10 | HP_0002140 |
| Disease | Deafness, Autosomal Recessive 12 | 3.78e-05 | 2 | 182 | 2 | C1832394 | |
| Disease | Autosomal recessive nonsyndromic hearing loss 12 | 3.78e-05 | 2 | 182 | 2 | cv:C1832394 | |
| Disease | autosomal recessive nonsyndromic deafness 12 (is_implicated_in) | 3.78e-05 | 2 | 182 | 2 | DOID:0110467 (is_implicated_in) | |
| Disease | DEAFNESS, AUTOSOMAL RECESSIVE 12 | 3.78e-05 | 2 | 182 | 2 | 601386 | |
| Disease | Nonorganic psychosis | 6.90e-05 | 69 | 182 | 5 | C0349204 | |
| Disease | systemic scleroderma, rheumatoid arthritis, myositis, systemic lupus erythematosus | 8.77e-05 | 38 | 182 | 4 | EFO_0000685, EFO_0000717, EFO_0000783, MONDO_0007915 | |
| Disease | multiple sclerosis | PITPNM2 TET2 TTC28 TENT4A MYO5B SIDT1 DOCK10 IFNAR1 SEPSECS IGF2R SKAP2 ALPK2 VDAC1 | 8.79e-05 | 594 | 182 | 13 | MONDO_0005301 |
| Disease | Agenesis of corpus callosum | 1.13e-04 | 3 | 182 | 2 | C0175754 | |
| Disease | interferon gamma measurement, platelet-derived growth factor BB measurement, interleukin 4 measurement, interleukin 10 measurement, stromal cell-derived factor 1 alpha measurement, interleukin-6 measurement, interleukin 12 measurement, interleukin 17 measurement, vascular endothelial growth factor measurement, fibroblast growth factor basic measurement, granulocyte colony-stimulating factor measurement | 1.22e-04 | 16 | 182 | 3 | EFO_0004750, EFO_0004753, EFO_0004762, EFO_0004810, EFO_0008130, EFO_0008142, EFO_0008165, EFO_0008174, EFO_0008184, EFO_0008264, EFO_0008293 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | TRHDE TET2 NYAP2 TTC28 MAP3K20 DOCK10 CDH23 ZNF407 GRIN2A DCC CDK14 GRM8 RAB7A PBX1 PRRC2B | 1.43e-04 | 801 | 182 | 15 | EFO_0003888, EFO_0007052, MONDO_0002491 |
| Disease | cortical thickness | PITPNM2 DPYSL2 RELN NYAP2 GLS2 CRIM1 RALGPS2 SIDT1 GALNT12 MSH3 CPM ADAMTSL3 PPP2R2A SEPSECS SMG7 GLS ASTN2 MTCH2 | 1.94e-04 | 1113 | 182 | 18 | EFO_0004840 |
| Disease | unipolar depression, smoking behaviour measurement | 2.25e-04 | 4 | 182 | 2 | EFO_0003761, EFO_0005671 | |
| Disease | Cholestasis, progressive familial intrahepatic 1 | 2.25e-04 | 4 | 182 | 2 | C4551898 | |
| Disease | myeloproliferative neoplasm (is_implicated_in) | 2.25e-04 | 4 | 182 | 2 | DOID:2226 (is_implicated_in) | |
| Disease | hepatitis (biomarker_via_orthology) | 2.25e-04 | 4 | 182 | 2 | DOID:2237 (biomarker_via_orthology) | |
| Disease | body fat distribution | 2.70e-04 | 202 | 182 | 7 | EFO_0004341 | |
| Disease | episodic memory | 3.01e-04 | 52 | 182 | 4 | EFO_0004333 | |
| Disease | glutamine measurement | 3.44e-04 | 97 | 182 | 5 | EFO_0009768 | |
| Disease | whole-brain volume | 3.74e-04 | 5 | 182 | 2 | EFO_0005089 | |
| Disease | Ovarian cyst | 3.74e-04 | 5 | 182 | 2 | HP_0000138 | |
| Disease | forced expiratory volume | TET2 TENT4B CRIM1 RALGPS2 GALNT12 GRIN2A DCC ADAMTSL3 ASTN2 KDM2A SKAP2 NNT MTCH2 PRRC2B | 4.10e-04 | 789 | 182 | 14 | EFO_0004314 |
| Disease | Psychotic Disorders | 4.15e-04 | 101 | 182 | 5 | C0033975 | |
| Disease | adverse effect, response to xenobiotic stimulus | 4.89e-04 | 59 | 182 | 4 | EFO_0009658, GO_0009410 | |
| Disease | pulmonary emphysema (biomarker_via_orthology) | 5.58e-04 | 6 | 182 | 2 | DOID:9675 (biomarker_via_orthology) | |
| Disease | Leukemia, Myelomonocytic, Chronic | 5.58e-04 | 6 | 182 | 2 | C0023480 | |
| Disease | Cholangitis, Sclerosing | 5.58e-04 | 6 | 182 | 2 | C0008313 | |
| Disease | age at menopause | 6.04e-04 | 302 | 182 | 8 | EFO_0004704 | |
| Disease | mean platelet volume | PITPNM2 TET2 GLS2 TTC28 MYO5A PCDHGA1 PECAM1 OR9Q1 EML6 SIDT1 DOCK10 GLS KIF28P PLCG2 PBX1 NNT | 6.15e-04 | 1020 | 182 | 16 | EFO_0004584 |
| Disease | susceptibility to hepatitis B infection measurement | 6.67e-04 | 64 | 182 | 4 | EFO_0008405 | |
| Disease | primary biliary cholangitis (biomarker_via_orthology) | 6.75e-04 | 28 | 182 | 3 | DOID:12236 (biomarker_via_orthology) | |
| Disease | cortical surface area measurement | PITPNM2 TET2 DCHS2 DPYSL2 RELN NYAP2 GLS2 RALGPS2 SIDT1 DOCK10 GALNT12 ADAMTSL3 TYR RND3 SEPSECS GLS ASTN2 MTCH2 DNAH11 | 6.85e-04 | 1345 | 182 | 19 | EFO_0010736 |
| Disease | acisoga measurement | 7.79e-04 | 7 | 182 | 2 | EFO_0800068 | |
| Disease | hereditary lymphedema (is_implicated_in) | 7.79e-04 | 7 | 182 | 2 | DOID:0050580 (is_implicated_in) | |
| Disease | aflatoxins-related hepatocellular carcinoma (biomarker_via_orthology) | 7.79e-04 | 7 | 182 | 2 | DOID:5022 (biomarker_via_orthology) | |
| Disease | venous thromboembolism, fibrinogen measurement | 7.93e-04 | 67 | 182 | 4 | EFO_0004286, EFO_0004623 | |
| Disease | melanoma | 9.15e-04 | 248 | 182 | 7 | C0025202 | |
| Disease | alcohol dependence (biomarker_via_orthology) | 1.03e-03 | 8 | 182 | 2 | DOID:0050741 (biomarker_via_orthology) | |
| Disease | Primary sclerosing cholangitis | 1.03e-03 | 8 | 182 | 2 | C0566602 | |
| Disease | Intestinal Diseases | 1.03e-03 | 8 | 182 | 2 | C0021831 | |
| Disease | Liver Cirrhosis, Experimental | VIPR1 GLS2 MYO5A PDGFRB DOCK10 ADD3 IGF2R NSMF GLS PLSCR2 SKAP2 NOS2 FMNL1 | 1.09e-03 | 774 | 182 | 13 | C0023893 |
| Disease | peak expiratory flow | TET2 GALNT12 ADAMTSL3 SLC15A1 GLCE ASTN2 KDM2A SKAP2 NNT MTCH2 | 1.11e-03 | 498 | 182 | 10 | EFO_0009718 |
| Disease | factor VIII measurement, venous thromboembolism | 1.20e-03 | 34 | 182 | 3 | EFO_0004286, EFO_0004630 | |
| Disease | chronotype measurement | RELN GLS2 CRIM1 TTC28 OR9Q1 MAP3K20 POU2F2 GCH1 UBXN4 KCNH2 GLS RHBDL3 PLCB4 MTCH2 | 1.20e-03 | 882 | 182 | 14 | EFO_0008328 |
| Disease | Amphetamine-Related Disorders | 1.21e-03 | 75 | 182 | 4 | C0236733 | |
| Disease | Amphetamine Abuse | 1.21e-03 | 75 | 182 | 4 | C0236807 | |
| Disease | Amphetamine Addiction | 1.21e-03 | 75 | 182 | 4 | C0236804 | |
| Disease | Schizophrenia | SHANK1 RELN MYO5B PDGFRB GCH1 GRIN2A DCC ADAMTSL3 GRM8 AQP4 TYR KCNH2 ASTN2 HDAC2 | 1.22e-03 | 883 | 182 | 14 | C0036341 |
| Disease | Silicosis | 1.32e-03 | 9 | 182 | 2 | C0037116 | |
| Disease | gallbladder neoplasm | 1.32e-03 | 9 | 182 | 2 | EFO_0004606 | |
| Disease | underweight body mass index status | 1.32e-03 | 9 | 182 | 2 | EFO_0005936 | |
| Disease | triglyceride change measurement, response to exercise | 1.32e-03 | 9 | 182 | 2 | EFO_0007681, EFO_0007768 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 1.37e-03 | 195 | 182 | 6 | DOID:1574 (implicated_via_orthology) | |
| Disease | threonine measurement | 1.54e-03 | 37 | 182 | 3 | EFO_0009775 | |
| Disease | uremia (biomarker_via_orthology) | 1.65e-03 | 10 | 182 | 2 | DOID:4676 (biomarker_via_orthology) | |
| Disease | alopecia areata (is_marker_for) | 1.65e-03 | 10 | 182 | 2 | DOID:986 (is_marker_for) | |
| Disease | membranoproliferative glomerulonephritis (implicated_via_orthology) | 1.65e-03 | 10 | 182 | 2 | DOID:2920 (implicated_via_orthology) | |
| Disease | breast carcinoma | SHANK1 TET2 LPCAT1 NYAP2 CYBRD1 TTC28 OR2J3 ADD3 SPPL2A ASTN2 COL14A1 GREB1 PBX1 NNT DNAH11 | 1.70e-03 | 1019 | 182 | 15 | EFO_0000305 |
| Disease | autosomal dominant nonsyndromic deafness (is_implicated_in) | 2.01e-03 | 11 | 182 | 2 | DOID:0050564 (is_implicated_in) | |
| Disease | Diarrhea | 2.01e-03 | 11 | 182 | 2 | C0011991 | |
| Disease | colonic neoplasm | 2.07e-03 | 41 | 182 | 3 | EFO_0004288 | |
| Disease | body weight | FOXO1 TET2 RELN ACP7 CYBRD1 EPHA6 CRIM1 NRCAM TENT4A ADGRB3 DCC ADAMTSL3 NBAS KCNH2 SPHKAP ASTN2 KDM2A | 2.15e-03 | 1261 | 182 | 17 | EFO_0004338 |
| Disease | venous thromboembolism, von Willebrand factor measurement | 2.22e-03 | 42 | 182 | 3 | EFO_0004286, EFO_0004629 | |
| Disease | primary immunodeficiency disease (is_implicated_in) | 2.22e-03 | 42 | 182 | 3 | DOID:612 (is_implicated_in) | |
| Disease | hemorrhoid | 2.23e-03 | 147 | 182 | 5 | EFO_0009552 | |
| Disease | childhood aggressive behaviour measurement | 2.27e-03 | 89 | 182 | 4 | EFO_0007663 | |
| Disease | endometrial carcinoma (is_implicated_in) | 2.40e-03 | 12 | 182 | 2 | DOID:2871 (is_implicated_in) | |
| Disease | Pathological accumulation of air in tissues | 2.40e-03 | 12 | 182 | 2 | C0013990 | |
| Disease | retinopathy of prematurity (biomarker_via_orthology) | 2.40e-03 | 12 | 182 | 2 | DOID:13025 (biomarker_via_orthology) | |
| Disease | Drug-induced depressive state | 2.40e-03 | 12 | 182 | 2 | C0338715 | |
| Disease | autistic disorder (is_marker_for) | 2.40e-03 | 12 | 182 | 2 | DOID:12849 (is_marker_for) | |
| Disease | Colonic Neoplasms | 2.58e-03 | 152 | 182 | 5 | C0009375 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 2.58e-03 | 152 | 182 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | reaction time measurement | TET2 DPYSL2 TTC28 MSH3 GRIN2A DCC GALNT13 PPP2R2A SMG7 ITSN2 DNAI4 | 2.70e-03 | 658 | 182 | 11 | EFO_0008393 |
| Disease | response to beta blocker | 2.71e-03 | 45 | 182 | 3 | EFO_0007766 | |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 2.71e-03 | 45 | 182 | 3 | DOID:3748 (is_implicated_in) | |
| Disease | homostachydrine measurement | 2.82e-03 | 13 | 182 | 2 | EFO_0021164 | |
| Disease | DEAFNESS, AUTOSOMAL RECESSIVE (disorder) | 2.82e-03 | 13 | 182 | 2 | C1846647 | |
| Disease | amyotrophic lateral sclerosis (biomarker_via_orthology) | 2.82e-03 | 13 | 182 | 2 | DOID:332 (biomarker_via_orthology) | |
| Disease | Malignant tumor of colon | 3.13e-03 | 159 | 182 | 5 | C0007102 | |
| Disease | dystonia (is_implicated_in) | 3.28e-03 | 14 | 182 | 2 | DOID:543 (is_implicated_in) | |
| Disease | diffuse large B-cell lymphoma | 3.28e-03 | 14 | 182 | 2 | EFO_0000403 | |
| Disease | Acute Confusional Senile Dementia | 3.34e-03 | 99 | 182 | 4 | C0546126 | |
| Disease | Alzheimer's Disease, Focal Onset | 3.34e-03 | 99 | 182 | 4 | C0750900 | |
| Disease | Alzheimer Disease, Early Onset | 3.34e-03 | 99 | 182 | 4 | C0750901 | |
| Disease | Presenile dementia | 3.34e-03 | 99 | 182 | 4 | C0011265 | |
| Disease | Alzheimer Disease, Late Onset | 3.34e-03 | 99 | 182 | 4 | C0494463 | |
| Disease | monocyte count | FOXO1 TET2 NYAP2 STAB2 GALNT1 PDGFRB MATN1 DOCK10 CDH23 POU2F2 PPIG LIMK1 SPPL2A CIITA ITSN2 RAB7A PBX1 | 3.43e-03 | 1320 | 182 | 17 | EFO_0005091 |
| Disease | Familial Alzheimer Disease (FAD) | 3.47e-03 | 100 | 182 | 4 | C0276496 | |
| Disease | eosinophilic esophagitis | 3.48e-03 | 163 | 182 | 5 | EFO_0004232 | |
| Disease | epilepsy (implicated_via_orthology) | 3.48e-03 | 163 | 182 | 5 | DOID:1826 (implicated_via_orthology) | |
| Disease | neurotic disorder | 3.59e-03 | 101 | 182 | 4 | EFO_0004257 | |
| Disease | Alzheimer's Disease | 3.59e-03 | 101 | 182 | 4 | C0002395 | |
| Disease | Replication Error Phenotype | 3.77e-03 | 15 | 182 | 2 | C1721098 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AGYQMNFETAKSRVT | 151 | P21796 | |
| FMKNYDGVAAASFSR | 981 | Q9UKU6 | |
| FSKAAQQTKGSYMEV | 266 | P55087 | |
| QYGDLNFAGMQNTTV | 331 | O14867 | |
| QFNGRSLMYFGSDKD | 311 | Q8WWN8 | |
| AYSGNNMDKSDSELN | 251 | Q53TN4 | |
| MKEERNYNFDGVSTN | 1 | A6NNP5 | |
| NGSDSVVMTGSYNNF | 351 | P63151 | |
| DFQNSYLMTGNVVAS | 691 | O60242 | |
| DAAVYQISAKNSFGM | 81 | Q86TB3 | |
| LQQIADYIMANSFSG | 91 | Q9UEY8 | |
| VMDVQYNKFTAAGAQ | 1076 | P33076 | |
| NQFKVTYDMIGGLSS | 346 | Q8NB90 | |
| AAAYNNFRKSMDSIG | 16 | O15123 | |
| VFNCSEQMDYKSIGN | 1916 | Q96DT5 | |
| SRTAQIMFQAYGDKQ | 1551 | Q13085 | |
| YMAATGLNATSGQDA | 931 | Q8NFM4 | |
| GFEKRAAASESNNYM | 51 | O94923 | |
| EAGESMRAFGKNNSY | 446 | O94921 | |
| SNEENGTIMFYKGFL | 121 | P00736 | |
| GLNSMFEVYLVGNNS | 381 | Q9H251 | |
| SMQQGKIAASYGNVI | 66 | Q9Y485 | |
| MGDMTNSDFYSKNQR | 1 | Q01814 | |
| GYTSGKEQQMAYNTL | 1211 | O75129 | |
| NEMKSYSQAVTGFFA | 216 | Q9Y6C9 | |
| ASSNKFVFGQNMSER | 316 | Q9H6Z4 | |
| YKFAGQMGIQLFETS | 136 | Q15286 | |
| NSNLFMSLNKDGSYT | 151 | Q9NS23 | |
| DSGVGKTSLMNQYVN | 16 | P51149 | |
| NAGLNVTVNATFMYS | 71 | P25092 | |
| DKSMSGYLSGFQARN | 256 | Q9NZM3 | |
| AAGKMNLYESFAQAT | 701 | Q68E01 | |
| FLNKMAGNEYVGFSN | 361 | O94925 | |
| NFSNYKARFSMPGDN | 211 | Q6ZNF0 | |
| NNKFRYAVFGLGSSM | 616 | P35228 | |
| GRSSYGAMQVKQAFD | 371 | Q8NDF8 | |
| AIEGAQAFYNGSLMA | 221 | A6NGU5 | |
| FTRMGAADNIYKGQS | 936 | P20585 | |
| LFMSVQSLNGDSYQG | 346 | P40424 | |
| TVNNQKYMSFTSGDK | 146 | O75914 | |
| LEKGSQYSFQVSAMT | 686 | P43146 | |
| QYSFQVSAMTVNGTG | 691 | P43146 | |
| QARMGVFAQADGSAY | 26 | Q9NPD3 | |
| IQLAFKMYGAQEDGS | 421 | Q8NF37 | |
| FMYLRGNSDQSSEKN | 256 | Q8NGQ5 | |
| ATVMFYAEKGTNKTN | 341 | Q9NSA2 | |
| VDSSGSSLQNGKYMQ | 846 | Q6ZMT4 | |
| LTGVNDKMAEYTNSA | 81 | O95249 | |
| GMVNYASTVKQEFSL | 81 | P21941 | |
| AIQYAMNVAFSVAEG | 116 | O95460 | |
| ISDAMYIFGGTVDNN | 396 | Q8N653 | |
| FGRTFYNQAIMSSKN | 191 | Q9HCC0 | |
| MGNSYAGQLKTTRFE | 1 | Q4ZG55 | |
| NYSFRVMAVNSIGKS | 716 | Q92823 | |
| QGMTSADDFFQGTKA | 81 | Q16555 | |
| FGNRNVFMKDNSSSS | 401 | Q96PV6 | |
| SYTNGIDMNAVLKGF | 706 | Q12809 | |
| NTGYAQKFQGRVTMT | 76 | P0DP01 | |
| VGNVTFSFDYQKTGM | 56 | P17181 | |
| FESSNMYEIKNSFGQ | 111 | Q9NRY7 | |
| EGKPFYQMTSNATQA | 541 | P16284 | |
| LAMGKLYGNDFSQTT | 226 | P09086 | |
| SAQGKQMIETYFDFR | 496 | Q6X4W1 | |
| NEYMGFSNATFQSEK | 301 | Q9UI32 | |
| GSQMVALNFQTADKY | 1006 | P16885 | |
| SQDGAKMVNAAVNTY | 481 | Q9P242 | |
| NLAYGDFIKSQEGMT | 536 | Q9BZ72 | |
| FFGTAQSAEKMYIQT | 801 | O00222 | |
| MGNSYAGQLKSARFE | 1 | Q9C091 | |
| YSRQGQEQDGIFKMS | 311 | A2RRP1 | |
| MGKLYGNDFSQTTIS | 216 | Q9UKI9 | |
| YTLQSFGEMADNFKS | 361 | P29375 | |
| GRSSYGAMQVKQVFD | 471 | Q5XG87 | |
| LAMGKLYGNDFSQTT | 311 | P14859 | |
| IGMNDSSQTGFQDKF | 1596 | P78509 | |
| EGVYFKLVNMQTSGS | 621 | P21439 | |
| NSQENMKVASIFYGT | 266 | Q8NH89 | |
| NGKVTYSILSGNENM | 1651 | Q6V1P9 | |
| SMANRGKDTNGSQFF | 111 | Q13427 | |
| MGGNQVFSYTADKEI | 461 | Q8IUC8 | |
| NSQENMKVAFIFYGT | 266 | Q8NH90 | |
| QTNMYAKKFQERFGS | 141 | Q8N414 | |
| TGFQATFMKIFGNDN | 1841 | O60494 | |
| GMGGNQVFSYTANKE | 461 | Q10472 | |
| TLQDNKSSYGGMSQY | 441 | Q12778 | |
| FYDKMQNAESGRGQV | 71 | P24001 | |
| TNKYNANFVTFMEGK | 46 | Q9Y2K7 | |
| VNNYISMFSSGDLKT | 1076 | Q96BY6 | |
| EGMEAFLKTVAQNYS | 26 | P14384 | |
| SAGFFMEELNTYRQK | 6 | P19525 | |
| KAFISNLNEMNDYAG | 71 | Q96RU3 | |
| SGMDYNVKIFASQAS | 891 | Q05707 | |
| KYNALVMSAFNNDAG | 376 | Q13616 | |
| FQGQYSVSDMKLRFS | 566 | Q8NBF6 | |
| GGAANLYRQSAMSFN | 1801 | Q5TH69 | |
| NFRDSAGAMKQINDY | 161 | P05154 | |
| NQFQDALYKMTGERT | 106 | Q9NS18 | |
| PDARFSGFYSMQKQN | 1011 | Q9NZV1 | |
| DKLRYVFSQMSDSNG | 146 | O60941 | |
| GMGQNQFFEYTSQKE | 481 | Q8IXK2 | |
| NAGGTYQNLDMVVSS | 251 | Q9BRF8 | |
| MSVYASLFKENNITG | 361 | Q9NYL2 | |
| FNSPGSYKTNAAAMN | 351 | Q71RC2 | |
| VLAFGNYMNSSKRGA | 841 | O95466 | |
| TSVKGYTGANQSRMA | 76 | Q5VTH9 | |
| TQQSFEMVKGGYTLD | 776 | Q08554 | |
| MDFSADGKYIQVSTG | 1821 | Q6ZMW3 | |
| SQNALGKYNTSMALF | 386 | Q86UP6 | |
| GTTMFSTLENNAIKY | 246 | A6NE01 | |
| SEYSKQMQRFNVGED | 86 | Q92769 | |
| QASSSYKIQMAEVGG | 181 | A5D8W1 | |
| LEKSNPYFMSGANSQ | 691 | P46059 | |
| KYAANNGVQMMTFDS | 121 | P11926 | |
| ALKVFYQSMNTARGQ | 906 | B7ZC32 | |
| AIEGAQAFYNGSLMA | 221 | P36268 | |
| FSYQVANGMEFLASK | 806 | P09619 | |
| GASGKVMDFNNGTYL | 151 | Q8N323 | |
| DQGVQGSATSQFYTM | 1286 | Q9BZA8 | |
| SEKGNSYKFQAGNRM | 541 | Q86X27 | |
| QGANMAKQIGAATYI | 161 | P61587 | |
| DAFNKGRANFSGMSE | 331 | P05120 | |
| FGQDLDVGMNSLQSY | 156 | Q9Y5H4 | |
| DSIKMGQYKNNFVAA | 971 | Q9UF33 | |
| QYRGKEYGQTMTVSN | 231 | O14896 | |
| MNDDGKVNASSEGYF | 1 | O76001 | |
| AQGYDALSSMANIAG | 186 | Q13423 | |
| AAANGSLSIMYVNGD | 1161 | P11717 | |
| YTDNIMKGFSAAAAI | 266 | P78382 | |
| YAGKNASSILNSAMQ | 1151 | Q2M3C7 | |
| AMAGSFLQDQFVSNY | 426 | Q16650 | |
| NMSSFNESVGLGYLK | 591 | Q15147 | |
| NIYQMATFGTTAGFS | 71 | Q8IUX1 | |
| YVFVSGKESRGSMNA | 501 | Q6IEE7 | |
| IFKGNSTRNVMYFNG | 2006 | P12259 | |
| MYFNGNSDASTIKEN | 2016 | P12259 | |
| ADGQIGYQDFVSLMS | 86 | P58872 | |
| GYQDFVSLMSNKRSN | 91 | P58872 | |
| KGEFAIDGYSVRMNN | 161 | O75563 | |
| CTQKAARNMSYQGFT | 326 | Q9P2J5 | |
| ARNMSYQGFTKDNGV | 331 | Q9P2J5 | |
| QRGVAAAMQYLSSFA | 776 | O15197 | |
| AMQFFTKGYQETISD | 101 | P30793 | |
| NNSMFNEVYGKNLTS | 946 | Q92540 | |
| GMESAANQKTSYFPN | 441 | P13521 | |
| MSFSGKYQLQSQENF | 1 | P07148 | |
| QEQFGSMAGSNVYLT | 316 | Q9H6W3 | |
| YMKFGSDTQASITLN | 306 | Q495N2 | |
| AMDGNSRAISKAFYS | 596 | Q9NRP7 | |
| GRSFMAVKSYQAQAE | 556 | Q9Y566 | |
| MIKAYNASFSENSTG | 486 | Q8TDI8 | |
| NNYQGGFGTTLMAKD | 271 | P31937 | |
| MRDVIGAATANQNYF | 441 | Q9NQW8 | |
| LNKQATTYGMADGDF | 221 | Q8N2M8 | |
| NKFASQQGMTAYGTR | 171 | P51911 | |
| EKRNYQVTNSMFGAS | 11 | Q9NZN8 | |
| MAAAGQEKGYLTQTA | 1 | Q8NEY3 | |
| MAGGKQFTFSYENEV | 1 | Q5SXH7 | |
| MYQAARAGGQAEATT | 226 | Q96HA9 | |
| LDEQQTMFYGSVKTG | 131 | P32241 | |
| RDMGYKNNFYSSQGI | 186 | O15393 | |
| AYAAKNAVTQFVSSM | 126 | P47985 | |
| AMFSYTFQVVQGNAD | 976 | Q9NZQ8 | |
| QYRVDTGNFQGMKVF | 446 | Q9P2C4 | |
| SDAANGMQYLSEKQF | 961 | P35590 | |
| MAETAAGVGRFKTNY | 1 | Q12788 | |
| VEFNGVYQSMTKKAA | 231 | Q9NXL6 | |
| SYKDFRDMNQTLGDN | 141 | Q8TCT8 | |
| NQGCNYSAMTKDALF | 1906 | O60281 | |
| NKSETGYVGLVNQAM | 181 | Q96K76 | |
| QYESGSMDKAANFSF | 326 | P14679 | |
| SGKQGQISSNYDDAM | 521 | Q9Y2X9 | |
| DYQKSSMGSMFRQQS | 466 | Q5JSZ5 | |
| GEAMKQFDLNYGSAI | 1526 | Q5JSZ5 | |
| ANVSMFFYNDLVNGT | 2381 | Q8WWQ8 | |
| SLGNTEKSTGYMQQD | 246 | Q96AY4 | |
| ANGSVSLQDMYGQEK | 51 | Q68EA5 | |
| NASMQGKNATYFSMA | 1116 | Q6R2W3 | |
| AGFNDSFIQEISKMY | 296 | Q9HD40 | |
| KGQAMYSFGRFDSSI | 1346 | Q9C0G0 | |
| NAYKRMSQIQAFLGS | 166 | Q6PP77 | |
| QTVGNTYGNFSLATM | 351 | Q92575 | |
| LKQNEMNGAYFKQSS | 371 | Q6N021 | |
| AMFSYTFGKVQGNSD | 1041 | Q8TD43 | |
| MATSNEGSKATYEQG | 61 | A0A075B6N2 | |
| EAAVKQGAYSMDTAQ | 1081 | P82987 | |
| QRVSFAKDIASGMAY | 436 | P53667 | |
| NDNSSRFGKYMDINF | 156 | O94832 | |
| YSGEEGFMKHNTSRQ | 1571 | Q9Y4I1 | |
| KQYSGDEGFMTQNTA | 1561 | Q9ULV0 | |
| SYVFQVQAMNSAGLG | 871 | Q5VTT5 | |
| SDKGNLMYSDNRSFQ | 936 | Q12879 |